Immunoassay Reagents and Devices Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Reagents and kits, Analyzers); Platform (Chemiluminescence immunoassays, Fluorescence immunoassays, Enzyme immunoassay, Radioimmunoassays, Others); Technique (Enzyme-linked immunosorbent assays, Rapid tests, Enzyme-linked immunospot, Western blotting, Immuno-PCR, Other techniques); Specimen type (Saliva, Urine, Blood, Others); Application (Infectious diseases, Oncology and endocrinology, Hematology and blood screening, Autoimmune disorders, Toxicology, Other applications); End user (Hospitals, Clinical laboratories, Blood banks, Research and academic laboratories, Others) and Geography
Report Code: TIPRE00024407
| No. of Pages: 150
| Category: Medical Device
| Status: Upcoming
Immunoassay is a test that is performed to detect specified molecules in laboratories. It relies on biochemistry to measure the presence and concentration of an analyte and depends on the antibody's ability to attach to the particular antigen present in the sample. Antibodies are produced in response to antigens in the body. Immunoassays are highly sensitive and specific, resulting from the use of antibodies and purified antigens as reagents.
The "Global Immunoassay Reagents and Devices Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the immunoassay reagents and devices market with detailed market segmentation by product, platform, technique, specimen type, application, end user, and geography. The report provides key statistics on the market status of the leading immunoassay reagents and devices market players and offers key trends and opportunities in the market.
Based on product, the global immunoassay reagents and devices market is segmented into reagents & kits and analyzers.
Based on platform, the market is segmented into chemiluminescence immunoassays, fluorescence immunoassays, enzyme immunoassay, radioimmunoassays and others.
Based on technique, the market is segmented into enzyme-linked immunosorbent assays, rapid tests, enzyme-linked immunospot, western blotting, immuno-PCR and other techniques.
On the basis of specimen type, the market is bifurcated into saliva, urine, blood and others.
Based on application, the market is segmented into infectious diseases, oncology & endocrinology, hematology & blood screening, autoimmune disorders, toxicology and other applications.
On the basis of end-users, the market is bifurcated into hospitals, clinical laboratories, blood banks, research and academic laboratories and others.
Rise in prevalence of diseases.
Technological advancement in immunoassay products for diagnosis.
Research and development in immunoassay reagents and devices.
Presence of alternative methods such as liquid chromatography-mass spectrometry technology.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The immunoassay reagents and devices market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the immunoassay reagents and devices market in these regions.
IMPACT OF COVID-19ON IMMUNOASSAY REAGENTS AND DEVICES MARKET
COVID-19 first began in Wuhan (China) during December 2019, and since then, it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, UK, Turkey, Italy, and Spain are some of the worst affected countries in terms of confirmed cases and reported deaths. The immunoassay product plays a vital role in controlling the spread of the COVID-19. In the absence of a vaccine or therapy, the diagnosis serves as an effective way to control and manage the spread of infections. The several immunoassay consumables and analyzers research & development and approvals have helped in COVID-19 detection. Various companies also launched immunoassay kits to identify antibodies to the coronavirus SARS-CoV-2, the virus associated with COVID-19. Furthermore, the increase in the use of immunoassays surged their demand. The mass scale diagnosis of COVID-19 also increased the market demand that helped in its growth. Therefore, the market is anticipated to grow in the forecast period.
Get more information on this report :
The report covers key developments in the immunoassay reagents and devices market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market players from immunoassay reagents and devices market are anticipated to have lucrative growth opportunities in the future with the rising demand for immunoassay reagents and devices in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the immunoassay reagents and devices market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
F. Hoffmann-La Roche Ltd
Bio-Rad Laboratories, Inc.
Thermo Fisher Scientific, Inc.
Beckman Coulter, Inc. (a subsidiary of Danaher)
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
Get more information on this report :
The List of Companies
1. F. Hoffmann-La Roche Ltd
2. Bio-Rad Laboratories, Inc.
4. Thermo Fisher Scientific, Inc.
5. Beckman Coulter, Inc. (a subsidiary of Danaher)
7. Merck KGaA
9. Sysmex Corporation
10. bioMérieux SA